Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,559.84
(
-0.79%
)
US TECH 100
23,260.60
(
-1.19%
)
Dow Jones
46,379.86
(
-0.62%
)
Brent Oil
107.59
(
0.49%
)
Bitcoin
68,062.51
(
-1.16%
)
News Focus
News Focus
Post# of 257367
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 36
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: Biowatch post# 5726

Wednesday, 12/15/2004 9:45:43 AM

Wednesday, December 15, 2004 9:45:43 AM

Post# of 257367
Can someone explain to me what's wrong with Indevus (IDEV)? The company is selling for about 2X cash. It has a best-in-its-class drug approved, SANCTURA, for a 2 billion-dollar market. Sales seem to be going well. The pipeline is interesting and moving along well. Management seems solid. Yet the stock is now selling for less than the day its drug was approved by the FDA.

Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today